Symbol Lookup

Saturday July 30, 2016 10:50 AM ET. Data delayed 15 minutes.
5.93
-0.08 (-1.33%)
Bid/Lots
5.93/2
Ask/Lots
5.94/2
Open/Prev Close
6.06/6.01
Day Range
5.81-6.06
52-Week Range
4.26-23.61
Vol/Avg Daily Vol
380.6K/1.2M

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
Cara Therapeutics to Announce Second Quarter 2016 Financial Results on August 4, 2016
8:01AM ET on Thursday Jul 28, 2016 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, August 4, 2016, at 4:30 p.m. ET to report second quarter 2016 financial results and provide a corporate update.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced t...

Jul 13, 2016

Cara Therapeutics' Data to be Presented at the British Association for Psychopharmacology 2016 Summer Meeting
4:30PM ET on Wednesday Jul 13, 2016 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that its preclinical data will be presented in a poster session at the British Association for Psychopharmacology (BAP) 2016 Summer Meeting, to be held in Brighton, UK from July 17 - 22, 2016.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced t...

Jul 5, 2016

Cara Therapeutics to Webcast Presentation at Cantor Fitzgerald's 2nd Annual Healthcare Conference
8:00AM ET on Tuesday Jul 05, 2016 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at Cantor Fitzgerald's 2 Annual Healthcare Conference on Tuesday, July 12, 2016, at 1:00 p.m. ET in New York City.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced t...

Why Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics
7:45AM ET on Tuesday Jul 05, 2016 by PR Newswire
Companies Mentioned: NAVB, XOMA, CARA, RDUS

The Biotech arena continues to compete with pricing pressures and economic uncertainty, but the overall performance of each operator varies on spending growth and demand. In today's pre-market research, Stock-Callers.com directs investors' attention to four stocks in this industry to review their recent performances: XOMA Corp. (NASDAQ: XOMA), Navidea Biopharmaceuticals Inc. (NYSE: NAVB), Radius Health Inc. (NASDAQ: RDUS), and Cara Therapeutics Inc. (NASDAQ: CARA). Learn more about these stocks and receive your complimentary trade alerts at:

The Biotech arena continues to compete with pricing pressures and economic uncertainty, but the overall performance of each operator varies on spending growth and demand. In today's pre-market research, Stock-Callers.com directs investors' atte...

Peers Headlines

Jul 7, 2016

Adverum Biotechnologies Provides wet AMD Program Update
4:15PM ET on Thursday Jul 07, 2016 by GlobeNewswire
Companies Mentioned: ADVM

Adverum Biotechnologies, Inc. (Nasdaq:ADVM) today announced the Company will continue to move forward with preclinical development of its anti-VEGF wAMD gene therapy candidates after analyzing promising pre-clinical data evaluating different co...

Jul 6, 2016

Bio-Path Holdings to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference
8:08AM ET on Wednesday Jul 06, 2016 by GlobeNewswire
Companies Mentioned: BPTH

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize(TM) liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that Peter H. Nie...